Co-Authors
This is a "connection" page, showing publications co-authored by Giordano Madeddu and A De Vito.
Connection Strength
3.952
-
Reply Letter - "Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis". Eur Rev Med Pharmacol Sci. 2021 03; 25(5):2161-2162.
Score: 0.932
-
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience. Eur Rev Med Pharmacol Sci. 2021 Jan; 25(1):523-526.
Score: 0.922
-
Editorial - HIV and cancer during COVID-19 pandemic: sailing through the perfect storm. Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13103-13104.
Score: 0.916
-
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy. Eur Rev Med Pharmacol Sci. 2020 07; 24(14):7861-7868.
Score: 0.890
-
Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19? Eur Rev Med Pharmacol Sci. 2021 Mar; 25(5):2435-2448.
Score: 0.233
-
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J Laryngol Otol. 2021 Aug; 135(8):723-728.
Score: 0.060